Novel high-performance liquid chromatography–tandem mass spectrometry method for simultaneous quantification of BCR-ABL and Bruton’s tyrosine kinase inhibitors and their three … Y Mukai, T Yoshida, T Kondo, N Inotsume, T Toda Journal of Chromatography B 1137, 121928, 2020 | 27 | 2020 |
Angiotensin II Receptor Blockers Inhibit the Generation of Epoxyeicosatrienoic Acid from Arachidonic Acid in Recombinant CYP 2C9, CYP 2J2 and Human Liver Microsomes A Senda, Y Mukai, T Hayakawa, Y Kato, E Eliasson, A Rane, T Toda, ... Basic & Clinical Pharmacology & Toxicology 121 (4), 239-245, 2017 | 18 | 2017 |
Effects of angiotensin II receptor blockers on metabolism of arachidonic acid via CYP2C8 A Senda, Y Mukai, T Toda, T Hayakawa, M Yamashita, E Eliasson, ... Biological and Pharmaceutical Bulletin 38 (12), 1975-1979, 2015 | 15 | 2015 |
Simultaneous quantification of BCR-ABL and Bruton tyrosine kinase inhibitors in dried plasma spots and its application to clinical sample analysis Y Mukai, Y Yoshida, T Yoshida, T Kondo, N Inotsume, T Toda Therapeutic Drug Monitoring 43 (3), 386-393, 2021 | 13 | 2021 |
The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study Y Kato, Y Mukai, A Rane, N Inotsume, T Toda Biological and Pharmaceutical Bulletin 40 (9), 1409-1415, 2017 | 13 | 2017 |
Drug− drug Interaction between Losartan and Paclitaxel in Human Liver Microsomes with Different CYP 2C8 Genotypes Y Mukai, A Senda, T Toda, T Hayakawa, E Eliasson, A Rane, N Inotsume Basic & Clinical Pharmacology & Toxicology 116 (6), 493-498, 2015 | 11 | 2015 |
Co-administration of fluvastatin and CYP3A4 and cyp2c8 inhibitors may increase the exposure to fluvastatin in carriers of CYP2C9 genetic variants Y Mukai, M Narita, E Akiyama, K Ohashi, Y Horiuchi, Y Kato, T Toda, ... Biological and Pharmaceutical Bulletin 40 (7), 1078-1085, 2017 | 10 | 2017 |
An liquid chromatography–tandem mass spectrometry method for the simultaneous determination of afatinib, alectinib, ceritinib, crizotinib, dacomitinib, erlotinib, gefitinib … Y Mukai, A Wakamoto, T Hatsuyama, T Yoshida, H Sato, A Fujita, ... Therapeutic Drug Monitoring 43 (6), 772-779, 2021 | 9 | 2021 |
Simultaneous determination method of epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids by LC-MS/MS system Y Mukai, T Toda, S Takeuchi, A Senda, M Yamashita, E Eliasson, A Rane, ... Biological and Pharmaceutical Bulletin 38 (10), 1673-1679, 2015 | 8 | 2015 |
Losartan competitively inhibits CYP2C8-dependent paclitaxel metabolism in vitro Y Mukai, T Toda, T Hayakawa, E Eliasson, A Rane, N Inotsume Biological and Pharmaceutical Bulletin 37 (9), 1550-1554, 2014 | 7 | 2014 |
Interior temperature and relative humidity of an envelope during mail transport by the Japan post in the summer: preliminary study for a stability test of dried blood spot … Y Mukai, R Minami, K Doki, N Inotsume, T Toda Therapeutic Drug Monitoring 41 (5), 628-633, 2019 | 4 | 2019 |
The Role of CYP2C8 and CYP2C9 Genotypes in Losartan‐Dependent Inhibition of Paclitaxel Metabolism in Human Liver Microsomes Y Mukai, A Senda, T Toda, E Eliasson, A Rane, N Inotsume Basic & Clinical Pharmacology & Toxicology 118 (6), 408-414, 2016 | 4 | 2016 |
Development and Validation of a Simple Method for Simultaneously Measuring the Concentrations of BCR-ABL and Bruton's Tyrosine Kinase Inhibitors in Dried Blood Spot (DBS): A … Y Mukai, T Yoshida, T Kondo, J Miura, N Inotsume, T Toda Therapeutic Drug Monitoring 44 (6), 762-770, 2022 | 2 | 2022 |
Concentration of Sulfate and Glucuronide Conjugates of Ritodrine in Twin Pregnancy M Soma, A Konda, S Fujieda, Y Sasaki, M Keira, H Yoshida, Y Mukai, ... Biological and Pharmaceutical Bulletin 40 (6), 922-925, 2017 | 2 | 2017 |
Utilizing the dry spot method to monitor the concentrations of biologic agents in breast milk Y Mukai, K Doki, Y Suzuki, M Homma British Journal of Clinical Pharmacology 90 (1), 368-369, 2024 | 1 | 2024 |
Effects of angiotensin II receptor blockers on serum levels of epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids in patients admitted to a cardiovascular center Y Kato, A Senda, Y Mukai, M Yamashita, Y Sasaoka, M Hanada, F Hongo, ... European Journal of Clinical Pharmacology 77, 887-894, 2021 | 1 | 2021 |
Combined effect of telmisartan and fluvastatin on arachidonic acid metabolism in human liver microsomes Y Kato, Y Mukai, A Rane, N Inotsume, T Toda Xenobiotica 48 (9), 898-903, 2018 | 1 | 2018 |
Elimination of ritodrine in mothers pregnant with twins and their neonatal twins S FUJIEDA, M KEIRA, M SOMA, Y SASAKI, A KONDA, Y MUKAI, T TODA, ... Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 48 …, 2017 | 1 | 2017 |
Pharmacokinetic study of erlotinib in a pregnant woman with advanced non‐small cell lung cancer and observation of the effects on the child growth Y Aida, M Ohgami, Y Mukai, M Matsuyama, M Obata‐Yasuoka, T Satoh, ... British Journal of Clinical Pharmacology 90 (10), 2554-2561, 2024 | | 2024 |
An analytical method using salting‐out assisted liquid–liquid extraction to quantify ceftriaxone from micro volumes of human serum Y Mukai, N Sugii, K Doki, M Homma Biomedical Chromatography 38 (9), e5955, 2024 | | 2024 |